{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:03:23Z","timestamp":1780445003034,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou National Laboratory","award":["SRPG22 018, SRPG22 016"],"award-info":[{"award-number":["SRPG22 018, SRPG22 016"]}]},{"name":"Guangzhou National Laboratory","award":["SRPG22 018, SRPG22 016"],"award-info":[{"award-number":["SRPG22 018, SRPG22 016"]}]},{"name":"the Foundation of Zhongnanshan Meical Foundation of Guangdong Province","award":["ZNSA-2021011"],"award-info":[{"award-number":["ZNSA-2021011"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970045, 81970038, and 82270043"],"award-info":[{"award-number":["81970045, 81970038, and 82270043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Plan on Enhancing Scientific Research in Guangzhou Medical University","award":["GMUCR2024-01012"],"award-info":[{"award-number":["GMUCR2024-01012"]}]},{"name":"the Clinical and Epidemiological Research Project of State Key Laboratory of Respiratory Disease","award":["SKLRD-L-202402"],"award-info":[{"award-number":["SKLRD-L-202402"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"DOI":"10.1038\/s41533-026-00501-w","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:17:15Z","timestamp":1775470635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying patients with mild-to-moderate COPD who require intensified initial treatment to control annualized clinically important deterioration"],"prefix":"10.1038","volume":"36","author":[{"given":"Zihui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-jie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-shan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pixin","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"501_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","volume":"207","author":"A Agust\u00ed","year":"2023","unstructured":"Agust\u00ed, A. et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive Summary. Am. J. respiratory Crit. Care Med. 207, 819\u2013837 (2023).","journal-title":"Am. J. respiratory Crit. Care Med."},{"key":"501_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-17686-9","volume":"24","author":"N Al Wachami","year":"2024","unstructured":"Al Wachami, N. et al. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMC Public Health 24, 297 (2024).","journal-title":"BMC Public Health"},{"key":"501_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13561-021-00329-9","volume":"11","author":"C Guti\u00e9rrez Villegas","year":"2021","unstructured":"Guti\u00e9rrez Villegas, C., Paz-Zulueta, M., Herrero-Montes, M., Par\u00e1s-Bravo, P. & Madrazo P\u00e9rez, M. Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review. Health Econ. Rev. 11, 31 (2021).","journal-title":"Health Econ. Rev."},{"key":"501_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/ijerph16010088","volume":"16","author":"CQ Ngo","year":"2018","unstructured":"Ngo, C. Q. et al. Direct hospitalization cost of patients with acute exacerbation of chronic obstructive pulmonary disease in vietnam. Int. J. Environ. Res. Public Health 16, 88 (2018).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"501_CR5","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa1700228","volume":"377","author":"Y Zhou","year":"2017","unstructured":"Zhou, Y. et al. Tiotropium in early-stage chronic obstructive pulmonary disease. N. Engl. J. Med. 377, 923\u2013935 (2017).","journal-title":"N. Engl. J. Med."},{"key":"501_CR6","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst, J. R. et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 363, 1128\u20131138 (2010).","journal-title":"N. Engl. J. Med."},{"key":"501_CR7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1164\/rccm.201404-0720OC","volume":"190","author":"A Ram\u00edrez-Venegas","year":"2014","unstructured":"Ram\u00edrez-Venegas, A. et al. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. Am. J. Respir. Crit. Care Med. 190, 996\u20131002 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"501_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/thx.2005.052241","volume":"61","author":"MH Brutsche","year":"2006","unstructured":"Brutsche, M. H. et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax 61, 671\u2013677 (2006).","journal-title":"Thorax"},{"key":"501_CR9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1164\/rccm.202303-0450OC","volume":"208","author":"SP Bhatt","year":"2023","unstructured":"Bhatt, S. P. et al. FEV(1)\/FVC severity stages for chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 208, 676\u2013684 (2023).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"501_CR10","doi-asserted-by":"publisher","first-page":"e003991","DOI":"10.1136\/bmjopen-2013-003991","volume":"4","author":"X Li","year":"2014","unstructured":"Li, X. et al. Early intervention with tiotropium in Chinese patients with GOLD stages I-II chronic obstructive pulmonary disease (Tie-COPD): study protocol for a multicentre, double-blinded, randomised, controlled trial. BMJ Open. 4, e003991 (2014).","journal-title":"BMJ Open."},{"key":"501_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1081\/COPD-200053377","volume":"2","author":"JF Donohue","year":"2005","unstructured":"Donohue, J. F. Minimal clinically important differences in COPD lung function. Copd 2, 111\u2013124 (2005).","journal-title":"Copd"},{"key":"501_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00047-2018","volume":"4","author":"I Naya","year":"2018","unstructured":"Naya, I. et al. Preventing clinically important deterioration with single-inhaler triple therapy in COPD. ERJ Open. Res. 4, 00047-2018 (2018).","journal-title":"ERJ Open. Res."},{"key":"501_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12931-020-01387-z","volume":"21","author":"D Singh","year":"2020","unstructured":"Singh, D. et al. Measuring disease activity in COPD: is clinically important deterioration the answer?. Respir. Res. 21, 134 (2020).","journal-title":"Respir. Res."},{"key":"501_CR14","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.chest.2017.10.009","volume":"153","author":"O Le Rouzic","year":"2018","unstructured":"Le Rouzic, O. et al. Defining the \u201cFrequent Exacerbator\u201d phenotype in COPD: A hypothesis-free approach. Chest 153, 1106\u20131115 (2018).","journal-title":"Chest"},{"key":"501_CR15","first-page":"50","volume":"115","author":"J Zheng","year":"2002","unstructured":"Zheng, J. & Zhong, N. Normative values of pulmonary function testing in Chinese adults. Chin. Med. J. 115, 50\u201354 (2002).","journal-title":"Chin. Med. J."},{"key":"501_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51079-1","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial. Nat. Commun. 15, 8468 (2024).","journal-title":"Nat. Commun."},{"key":"501_CR17","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","volume":"365","author":"J Vestbo","year":"2011","unstructured":"Vestbo, J. et al. Changes in forced expiratory volume in 1 second over time in COPD. N. Engl. J. Med. 365, 1184\u20131192 (2011).","journal-title":"N. Engl. J. Med."},{"key":"501_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.20982\/tqmp.14.2.p099","volume":"14","author":"C Muth","year":"2018","unstructured":"Muth, C., Oravecz, Z. & Gabry, J. User-friendly Bayesian regression modeling: A tutorial with rstanarm and shinystan. The Quantitative Methods for Psychology 14, 99\u2013119 (2018).","journal-title":"The Quantitative Methods for Psychology"},{"key":"501_CR19","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/all.13760","volume":"74","author":"PJ Barnes","year":"2019","unstructured":"Barnes, P. J. Inflammatory endotypes in COPD. Allergy 74, 1249\u20131256 (2019).","journal-title":"Allergy"},{"key":"501_CR20","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1183\/09031936.00162414","volume":"44","author":"D Singh","year":"2014","unstructured":"Singh, D. et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur. Respir. J. 44, 1697\u20131700 (2014).","journal-title":"Eur. Respir. J."},{"key":"501_CR21","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/thoraxjnl-2016-209846","volume":"72","author":"PJ Castaldi","year":"2017","unstructured":"Castaldi, P. J. et al. Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts. Thorax 72, 998\u20131006 (2017).","journal-title":"Thorax"},{"key":"501_CR22","doi-asserted-by":"publisher","first-page":"111590","DOI":"10.1016\/j.ecoenv.2020.111590","volume":"208","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Association of change in air quality with hospital admission for acute exacerbation of chronic obstructive pulmonary disease in Guangdong, China: A province-wide ecological study. Ecotoxicol. Environ. Saf. 208, 111590 (2021).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"501_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1136\/thx.2006.073015","volume":"62","author":"H Kan","year":"2007","unstructured":"Kan, H. et al. Traffic exposure and lung function in adults: the Atherosclerosis Risk in Communities Study. Thorax 62, 873\u2013879 (2007).","journal-title":"Thorax"},{"key":"501_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fphys.2015.00294","volume":"6","author":"L Ni","year":"2015","unstructured":"Ni, L., Chuang, C. C. & Zuo, L. Fine particulate matter in acute exacerbation of COPD. Front. Physiol. 6, 294 (2015).","journal-title":"Front. Physiol."},{"key":"501_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1513\/pats.2306030","volume":"1","author":"JA Wedzicha","year":"2004","unstructured":"Wedzicha, J. A. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 1, 115\u2013120 (2004).","journal-title":"Proc. Am. Thorac. Soc."},{"key":"501_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/thx.2003.006502","volume":"59","author":"DL DeMeo","year":"2004","unstructured":"DeMeo, D. L. & Silverman, E. K. Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 59, 259\u2013264 (2004).","journal-title":"Thorax"},{"key":"501_CR27","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","volume":"374","author":"JA Wedzicha","year":"2016","unstructured":"Wedzicha, J. A. et al. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. N. Engl. J. Med. 374, 2222\u20132234 (2016).","journal-title":"N. Engl. J. Med."},{"key":"501_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1916046","volume":"383","author":"KF Rabe","year":"2020","unstructured":"Rabe, K. F. et al. Triple inhaled therapy at two glucocorticoid doses in Moderate-to-Very-Severe COPD. N. Engl. J. Med. 383, 35\u201348 (2020).","journal-title":"N. Engl. J. Med."},{"key":"501_CR29","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","volume":"378","author":"DA Lipson","year":"2018","unstructured":"Lipson, D. A. et al. Once-Daily single-inhaler triple versus dual therapy in patients with COPD. N. Engl. J. Med. 378, 1671\u20131680 (2018).","journal-title":"N. Engl. J. Med."},{"key":"501_CR30","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2147\/COPD.S307160","volume":"16","author":"GT Ferguson","year":"2021","unstructured":"Ferguson, G. T., Kerwin, E. M., Rheault, T., Bengtsson, T. & Rickard, K. A dose-ranging study of the novel Inhaled dual PDE 3 and 4 inhibitor ensifentrine in patients with COPD receiving maintenance tiotropium therapy. Int. J. Chron. Obstr. Pulmon. Dis. 16, 1137\u20131148 (2021).","journal-title":"Int. J. Chron. Obstr. Pulmon. Dis."},{"key":"501_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1378\/chest.117.3.672","volume":"117","author":"IM Ferreira","year":"2000","unstructured":"Ferreira, I. M., Brooks, D., Lacasse, Y. & Goldstein, R. S. Nutritional support for individuals with COPD: a meta-analysis. Chest 117, 672\u2013678 (2000).","journal-title":"Chest"},{"key":"501_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.clnu.2005.01.005","volume":"24","author":"M Planas","year":"2005","unstructured":"Planas, M. et al. Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients. Clin. Nutr. 24, 433\u2013441 (2005).","journal-title":"Clin. Nutr."},{"key":"501_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1183\/09059180.00007212","volume":"22","author":"P T\u00f8nnesen","year":"2013","unstructured":"T\u00f8nnesen, P. Smoking cessation and COPD. Eur. Respir. Rev. 22, 37\u201343 (2013).","journal-title":"Eur. Respir. Rev."},{"key":"501_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11606-009-0907-y","volume":"24","author":"DH Au","year":"2009","unstructured":"Au, D. H. et al. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J. Gen. Intern. Med. 24, 457\u2013463 (2009).","journal-title":"J. Gen. Intern. Med."},{"key":"501_CR35","first-page":"35","volume":"144","author":"R Jaeschke","year":"1991","unstructured":"Jaeschke, R., Guyatt, G. H., Singer, J., Keller, J. & Newhouse, M. T. Mechanism of bronchodilator effect in chronic airflow limitation. CMAJ 144, 35\u201339 (1991).","journal-title":"CMAJ"},{"key":"501_CR36","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1378\/chest.125.6.2011","volume":"125","author":"P Wongsurakiat","year":"2004","unstructured":"Wongsurakiat, P. et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 125, 2011\u20132020 (2004).","journal-title":"Chest"},{"key":"501_CR37","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1016\/j.vaccine.2008.05.037","volume":"26","author":"A Furumoto","year":"2008","unstructured":"Furumoto, A. et al. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine 26, 4284\u20134289 (2008).","journal-title":"Vaccine"},{"key":"501_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(05)67100-0","volume":"366","author":"KF Rabe","year":"2005","unstructured":"Rabe, K. F. et al. Roflumilast\u2013an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 366, 563\u2013571 (2005).","journal-title":"Lancet"},{"key":"501_CR39","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","volume":"377","author":"ID Pavord","year":"2017","unstructured":"Pavord, I. D. et al. Mepolizumab for eosinophilic chronic obstructive pulmonary disease. N. Engl. J. Med. 377, 1613\u20131629 (2017).","journal-title":"N. Engl. J. Med."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00501-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00501-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00501-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:13:58Z","timestamp":1780442038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00501-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["501"],"URL":"https:\/\/doi.org\/10.1038\/s41533-026-00501-w","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines and was approved by the ethics committee of the First Affiliated Hospital of Guangzhou Medical University, and all participants signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}}],"article-number":"34"}}